Objectives: To study and compare the effectiveness of p16INK4a staining and specific human papillomavirus (HPV) subtypes as a prognostic marker in cervical intraepithelial neoplasia grade 1 (CIN1; low-grade squamous intraepithelial lesions). Methods: Sixty-four cervical samples diagnosed as CIN1 and stained with p16INK4a, with HPV status assessed by polymerase chain reaction–direct sequencing. Results: Of the 34 p16INK4a-negative biopsy specimens, 26 regressed, seven persisted, and one progressed. Of the 20 p16INK4a diffusely positive biopsy specimens, seven regressed, eight persisted, and five progressed. Ten biopsy specimens stained positive only in the lower one-third of the sample, of which seven regressed and three persisted. p16INK4a ...
<div><p>The objective of this study was to compare the accuracies of double staining for p16/Ki-67 a...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
The aim of this thesis is to identify clinically useful early molecular markers to predict progressi...
Usubutun, Alp/0000-0001-9572-7875;WOS: 000259270800015PubMed: 18958930Aim: The aims of this study we...
Grading cervical intraepithelial neoplasia (CIN) determines clinical management of women after abnor...
As only a minority of low-grade dysplastic lesions of the cervix uteri will eventually progress to c...
INTRODUCTION: Immunostaining with p16INK4a (p16), a tumor-suppressor surrogate protein biomarker for...
As only a minority of low-grade dysplastic lesions of the cervix uteri will eventually progress to c...
Purpose of investigation: The aim of this prospective study was the evaluation of low-grade intraepi...
OBJECTIVE: The p16 (p16(Ink4a)) tumor-suppressor protein is a biomarker for activated expression of...
Objective This study aimed at evaluating whether human papillomavirus (HPV) groups and E6/E7 mRNA of...
To assess the role of p16INK4A, bcl-2, and p53 in cervical cancer screening, we conducted a retrospe...
Summary: The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigat...
Context.—Lower Anogenital Squamous Terminology (LAST) standardization recommended p16INK4a immunohis...
CONTEXT.—: Lower Anogenital Squamous Terminology (LAST) standardization recommended p16INK4a immunoh...
<div><p>The objective of this study was to compare the accuracies of double staining for p16/Ki-67 a...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
The aim of this thesis is to identify clinically useful early molecular markers to predict progressi...
Usubutun, Alp/0000-0001-9572-7875;WOS: 000259270800015PubMed: 18958930Aim: The aims of this study we...
Grading cervical intraepithelial neoplasia (CIN) determines clinical management of women after abnor...
As only a minority of low-grade dysplastic lesions of the cervix uteri will eventually progress to c...
INTRODUCTION: Immunostaining with p16INK4a (p16), a tumor-suppressor surrogate protein biomarker for...
As only a minority of low-grade dysplastic lesions of the cervix uteri will eventually progress to c...
Purpose of investigation: The aim of this prospective study was the evaluation of low-grade intraepi...
OBJECTIVE: The p16 (p16(Ink4a)) tumor-suppressor protein is a biomarker for activated expression of...
Objective This study aimed at evaluating whether human papillomavirus (HPV) groups and E6/E7 mRNA of...
To assess the role of p16INK4A, bcl-2, and p53 in cervical cancer screening, we conducted a retrospe...
Summary: The expressions of p16, Ki-67, and L1 proteins and human papillomavirus DNA were investigat...
Context.—Lower Anogenital Squamous Terminology (LAST) standardization recommended p16INK4a immunohis...
CONTEXT.—: Lower Anogenital Squamous Terminology (LAST) standardization recommended p16INK4a immunoh...
<div><p>The objective of this study was to compare the accuracies of double staining for p16/Ki-67 a...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
The aim of this thesis is to identify clinically useful early molecular markers to predict progressi...